ASTRIA THERAPEUTICS, INC. 

75 State Street 

Suite 1400 

Boston, Massachusetts 02109

 

December 28, 2023

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:	Astria Therapeutics, Inc.
	Registration Statement on Form S-3
	File No. 333-276057
	Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Astria Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-276057), so that it may become effective at 4:30 p.m. Eastern time on December 29, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

 

	Very truly yours,
	ASTRIA THERAPEUTICS, INC.
	By:	/s/ Ben Harshbarger
	Name:	Ben Harshbarger
	Title:	Chief Legal Officer and Corporate Secretary

 

cc:	Rosemary G. Reilly, Esq.

Wilmer Cutler Pickering Hale and Dorr LLP